Rifaximin systemic absorption in patients with ulcerative colitis

[1] VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J]. BRITISH MEDICAL JOURNAL, 1964, 1 (5374): : 89 - +

[2] BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123

[3] CAHDWICK VS, 1992, INFLAMM BOWEL DIS, P241

[4] CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J]. GUT, 1986, 27 (10) : 1210 - 1212

[5] DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51

[6] DOUBLE-BLIND CONTROLLED TRIAL OF ORAL VANCOMYCIN AS ADJUNCTIVE TREATMENT IN ACUTE EXACERBATIONS OF IDIOPATHIC COLITIS [J]. GUT, 1985, 26 (12) : 1380 - 1384

[7] RIFAXIMIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN CONDITIONS MEDIATED BY GASTROINTESTINAL BACTERIA [J]. DRUGS, 1995, 49 (03) : 467 - 484

[8] GIONCHETTI P, 1997, IN PRESS DIG DIS SCI

[9] ANTIMICROBIAL ACTIVITY AND SPECTRUM OF RIFAXIMIN, A NEW TOPICAL RIFAMYCIN DERIVATIVE [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 16 (02) : 111 - 118

[10] MANTZARIS GJ, 1994, AM J GASTROENTEROL, V89, P43

[1] VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J]. BRITISH MEDICAL JOURNAL, 1964, 1 (5374): : 89 - +

[2] BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123

[3] CAHDWICK VS, 1992, INFLAMM BOWEL DIS, P241

[4] CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J]. GUT, 1986, 27 (10) : 1210 - 1212

[5] DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51

[6] DOUBLE-BLIND CONTROLLED TRIAL OF ORAL VANCOMYCIN AS ADJUNCTIVE TREATMENT IN ACUTE EXACERBATIONS OF IDIOPATHIC COLITIS [J]. GUT, 1985, 26 (12) : 1380 - 1384

[7] RIFAXIMIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN CONDITIONS MEDIATED BY GASTROINTESTINAL BACTERIA [J]. DRUGS, 1995, 49 (03) : 467 - 484

[8] GIONCHETTI P, 1997, IN PRESS DIG DIS SCI

[9] ANTIMICROBIAL ACTIVITY AND SPECTRUM OF RIFAXIMIN, A NEW TOPICAL RIFAMYCIN DERIVATIVE [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 16 (02) : 111 - 118

[10] MANTZARIS GJ, 1994, AM J GASTROENTEROL, V89, P43